"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
THROMBIN-JMI (thrombin topical bovine origin) ® is contraindicated in persons known to be sensitive to any of its components and/or to material of bovine origin.
Last reviewed on RxList: 10/14/2008
This monograph has been modified to include the generic and brand name in many instances.
Additional Thrombin-JMI Information
Report Problems to the Food and Drug Administration
Find out what women really need.